CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 158 filers reported holding CONMED CORP in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,572,832 | -54.4% | 65,967 | -47.3% | 0.00% | -75.0% |
Q1 2024 | $10,028,340 | -29.7% | 125,229 | -3.8% | 0.00% | -33.3% |
Q4 2023 | $14,260,282 | +23.1% | 130,219 | +13.4% | 0.01% | +20.0% |
Q3 2023 | $11,579,696 | +268.6% | 114,821 | +279.6% | 0.01% | +150.0% |
Q2 2023 | $3,141,660 | 0.0% | 30,249 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $3,141,660 | +15.0% | 30,249 | -1.9% | 0.00% | +100.0% |
Q4 2022 | $2,732,505 | -99.9% | 30,827 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $2,471,400,000 | -23.6% | 30,827 | -8.8% | 0.00% | -50.0% |
Q2 2022 | $3,235,155,000 | -36.0% | 33,784 | -0.8% | 0.00% | 0.0% |
Q1 2022 | $5,057,384,000 | +6.7% | 34,045 | +1.8% | 0.00% | 0.0% |
Q4 2021 | $4,739,887,000 | +6.8% | 33,436 | -1.4% | 0.00% | 0.0% |
Q3 2021 | $4,438,670,000 | -6.0% | 33,927 | -1.3% | 0.00% | 0.0% |
Q2 2021 | $4,722,096,000 | +4.7% | 34,360 | -0.5% | 0.00% | 0.0% |
Q1 2021 | $4,508,490,000 | +17.1% | 34,524 | +0.5% | 0.00% | 0.0% |
Q4 2020 | $3,849,328,000 | +38.6% | 34,369 | -2.6% | 0.00% | +100.0% |
Q3 2020 | $2,777,129,000 | +22.5% | 35,301 | +12.1% | 0.00% | 0.0% |
Q2 2020 | $2,267,541,000 | +17.1% | 31,498 | -6.8% | 0.00% | 0.0% |
Q1 2020 | $1,936,185,000 | -50.1% | 33,808 | -2.5% | 0.00% | -50.0% |
Q4 2019 | $3,877,034,000 | +17.7% | 34,669 | +1.2% | 0.00% | 0.0% |
Q3 2019 | $3,293,331,000 | +40.0% | 34,252 | +24.6% | 0.00% | 0.0% |
Q2 2019 | $2,352,234,000 | +33.0% | 27,489 | +29.3% | 0.00% | +100.0% |
Q1 2019 | $1,767,992,000 | +42.1% | 21,255 | +9.7% | 0.00% | 0.0% |
Q4 2018 | $1,243,811,000 | -15.6% | 19,374 | +4.1% | 0.00% | 0.0% |
Q3 2018 | $1,473,809,000 | +8.4% | 18,604 | +0.2% | 0.00% | 0.0% |
Q2 2018 | $1,359,397,000 | +21.8% | 18,571 | +5.4% | 0.00% | 0.0% |
Q1 2018 | $1,116,065,000 | +73.0% | 17,623 | +39.2% | 0.00% | 0.0% |
Q4 2017 | $645,280,000 | -2.9% | 12,660 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $664,271,000 | +3.9% | 12,660 | +0.8% | 0.00% | 0.0% |
Q2 2017 | $639,602,000 | +14.8% | 12,556 | +0.1% | 0.00% | 0.0% |
Q1 2017 | $557,035,000 | +164217.1% | 12,543 | +63.2% | 0.00% | – |
Q4 2016 | $339,000 | -48.1% | 7,684 | -52.9% | 0.00% | -100.0% |
Q3 2016 | $653,000 | -16.1% | 16,299 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $778,000 | +13.7% | 16,299 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $684,000 | -10.7% | 16,299 | -6.3% | 0.00% | 0.0% |
Q4 2015 | $766,000 | -7.8% | 17,399 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $831,000 | -18.0% | 17,399 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $1,014,000 | +27.9% | 17,399 | +10.8% | 0.00% | 0.0% |
Q1 2015 | $793,000 | +14.6% | 15,699 | +1.9% | 0.00% | 0.0% |
Q4 2014 | $692,000 | +22.0% | 15,399 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $567,000 | -16.6% | 15,399 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $680,000 | +7.3% | 15,399 | +5.5% | 0.00% | 0.0% |
Q1 2014 | $634,000 | +28.6% | 14,599 | +25.9% | 0.00% | 0.0% |
Q4 2013 | $493,000 | +17.1% | 11,599 | -6.5% | 0.00% | 0.0% |
Q3 2013 | $421,000 | +8.8% | 12,399 | 0.0% | 0.00% | – |
Q2 2013 | $387,000 | – | 12,399 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |